GI
BIOX icon

Gradient Investments’s Bioceres Crop Solutions BIOX Stock Holding History

Gradient Investments’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70
Closed -$785 – 395
2024
Q2 		$785 Hold
70
– – ﹤0.01% 1112
2024
Q1 		$886 Hold
70
– – ﹤0.01% 927
2023
Q4 		$961 Hold
70
– – ﹤0.01% 1439
2023
Q3 		$790 Hold
70
– – ﹤0.01% 1441
2023
Q2 		$935 Hold
70
– – ﹤0.01% 1382
2023
Q1 		$813 Hold
70
– – ﹤0.01% 1227
2022
Q4 		$842 Hold
70
– – ﹤0.01% 1224
2022
Q3 		$1K Buy
+70
New +$859 ﹤0.01% 1204

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Gradient Investments's BIOX Position: Q3 2024 in Review

Gradient Investments sold out of Bioceres Crop Solutions (BIOX) in Q3 2024, closing a stake of 70 shares — an estimated $785 sold.

Gradient Investments first reported a position in BIOX in Q3 2022 and held it in 8 quarters. The position peaked at $1K in Q3 2022. 48 funds tracked by Wall St. Rank hold BIOX as of Q3 2024.

  • Gradient Investments reported no remaining Bioceres Crop Solutions position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 70 Bioceres Crop Solutions shares in Q3 2024, an estimated $785.
  • Gradient Investments first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 8 quarters.
  • Gradient Investments's Bioceres Crop Solutions position peaked at $1K in Q3 2022.
  • 48 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.